Vaccination News

Adults who received the recombinant zoster vaccine had a significantly lower risk for dementia over the next 6 years compared with live vaccine recipients, study results published in Nature Medicine revealed.

WHO this week announced a project to speed development of a messenger RNA vaccine against highly pathogenic avian influenza in humans.

Two experimental HIV vaccine regimens failed to reduce infections in a 3-year trial in eastern and southern Africa compared with participants who were taking a placebo, some of whom were on oral PrEP, according to a study.

The Pan American Health Organization issued an epidemiological alert in July regarding a significant rise in pertussis cases in the Americas and across the globe, according to a press release.

Influenza is responsible for significant mortality and hospitalization rates in the United States, ranging from 4,900 to 51,000 deaths and 100,000 to 710,000 hospitalizations annually between 2010 and 2023, according to the CDC.

With roughly 7% of adults in the United States reporting that they have had long COVID, primary care providers can play an important role in its prevention and management, according to experts.

Researchers developed a low-cost rapid test to detect an invasive species of mosquito that has adapted to live near humans in urban environments, which they hope can be used in areas far from medical labs.

Throughout the course of human history, one infectious disease (Figure 1) may account for more deaths than any other, perhaps all others combined.

The risk for developing long COVID declined over the course of the pandemic but has remained significant, researchers reported.

Ivory Coast administered the first doses of the world’s second malaria vaccine this week, according to the vaccine’s manufacturers, marking the latest development in a decades-long effort to control the deadly mosquito-borne disease.